On 11 December, Agenus Inc. (NASDAQ:AGEN) said that Ludwig Cancer Research announced an agreement with Agenus that grants the Lexington, MA-based biotechnology company exclusive license to further develop and commercialize antibodies against three molecules—GITR, OX40 and TIM3—that play distinct and important roles in immune cell regulation and have been identified and assessed as drug targets by Ludwig researchers. Agenus Inc. (NASDAQ:AGEN) in last trading activity increased 1.53% to close at $3.99. Company weekly performance is 23.91% while its quarterly performance stands at 38.54%. Agenus Inc. (NASDAQ:AGEN) is -24.29% away from its 52 week high.
Jefferies Group lowered their price objective on shares of Olympic Steel Inc. (NASDAQ:ZEUS) from $22.50 to $18.00 in a research note issued on Wednesday. The firm currently has a “hold” rating on the stock. Jefferies Group’s price objective suggests a potential upside of 10.23% from the company’s current price. On last trading day Olympic Steel Inc. (NASDAQ:ZEUS) increased 8.54% to close at $18.17. Its volatility for the week is 6.69% while volatility for the month is 4.79%. ZEUS’s sales growth for past 5 years was 0.60% and its EPS growth for past 5 years was -35.60%. Olympic Steel Inc. (NASDAQ:ZEUS) monthly performance is 6.57%.
On 16 December DURECT Corporation (NASDAQ:DRRX) has entered into an agreement with Santen Pharmaceutical Co., Ltd. granting Santen the exclusive worldwide rights to develop and commercialize a sustained release product utilizing DURECT’s SABER technology to deliver an ophthalmology drug. On last trading day DURECT Corporation (NASDAQ:DRRX) fell -6.90% to close at $0.81. Its volatility for the week is 7.32% while volatility for the month is 8.10%. DRRX’s sales growth for past 5 years was -11.70% and its EPS growth for past 5 years was 17.80%. DURECT Corporation (NASDAQ:DRRX) monthly performance is -10.99%.
On 16 December, Vectren Corporation (NYSE:VVC) issued an update on its FY15 earnings guidance on Tuesday morning. The company provided earnings per share guidance of $2.40-2.55 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $2.47. Vectren Corporation (NYSE:VVC) has 0.10% insider ownership while its institutional ownership stands at 60.30%. In last trading activity company’s stock closed at $44.54.
On 10 December, Willamette Valley Vineyards Inc. (NASDAQ:WVVI) said that it has released its 2014 Holiday Food & Wine Pairing Guide on its website. On Friday shares of Willamette Valley Vineyards Inc. (NASDAQ:WVVI) closed at $5.85. Company’s sales growth for last 5 years was -3.60%